MOREPEN LABORATORIES
Back to Income Statement
|
MOREPEN LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹118 Cr | ₹96 Cr | ₹39 Cr | ₹102 Cr | ₹97 Cr |
What is the latest Consolidated Net Profit of MOREPEN LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹118 Cr |
| Mar2024 | ₹96 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹102 Cr |
| Mar2021 | ₹97 Cr |
How is Consolidated Net Profit of MOREPEN LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹118 Cr | 22.73 | |
| Mar2024 | ₹96 Cr | 148.64 | |
| Mar2023 | ₹39 Cr | -61.97 | |
| Mar2022 | ₹102 Cr | 4.73 | |
| Mar2021 | ₹97 Cr | - | |
Compare Consolidated Net Profit of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹2,118.6 Cr | -5.7% | -6.7% | -47.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,728.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,627.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -5.7% |
-6.7% |
-47.3% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses